Niaprazine is an antidepressant medication belonging to the tricyclic antidepressant (TCA) class of drugs. It is used to treat major depression and other mental health disorders, such as obsessive-compulsive disorder (OCD), panic disorder, and bulimia nervosa. It works by increasing the levels of certain neurotransmitters in the brain, such as serotonin and norepinephrine, which are thought to be involved in mood regulation. Niaprazine may be used as part of a combination therapy, meaning that it may be combined with other medications to treat depression. Common side effects of Niaprazine include dry mouth, constipation, blurred vision, and drowsiness.
Niaprazine is a sedative-hypnotic medication that was previously used in some European countries to treat sleep disorders, particularly in children and adolescents. It was marketed under the brand name Nopron.
Here's a breakdown of some key points about Niaprazine:
- Function: Originally thought to work as an antihistamine and anticholinergic, Niaprazine was later discovered to act as a serotonin (5-HT2A) and alpha-1 adrenergic receptor antagonist.
- Use: Niaprazine was prescribed for occasional sleep problems in children and adolescents due to its favorable safety profile and lack of dependence potential.
- Availability: Niaprazine is not currently available in the United States or many other countries. Its development was discontinued due to the emergence of safer and more effective sleep medications.